CD274 and esophageal squamous cell carcinoma: Although these results should be considered within the context of the differing PD-L1 expression scoring systems used across the included trials, a relatively high concordance between TAP score and CPS has been reported in terms of OPA (90% [95% CI: 86-93]) in the ESCC trial population (48).